Status:
COMPLETED
Maternal Health Diabetes Prevention Study
Lead Sponsor:
Tulane University
Collaborating Sponsors:
Westat
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Gestational Diabetes
PreDiabetes
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The aim of this project is to use the Exploration, Preparation, Implementation, Sustainment (EPIS) framework to collect pilot data on the implementation of a Diabetes Prevention Program-like intervent...
Detailed Description
In this study, investigators will pilot a 2-month Diabetes Prevention Program-like program (delivered by WIC staff) to 20 women with recent gestational diabetes (6 weeks to 12 months postpartum) who r...
Eligibility Criteria
Inclusion
- Age ≥18 years
- 6 weeks to 12 months postpartum
- Medical record documented diagnosis of GDM during most recent pregnancy
- Access to a device that can access the internet
- English speaking
Exclusion
- Pregnant or planning to become pregnant in the next two months
- Planning to move out of the area in the next two months
- Self-report of diagnosed diabetes
- Use of glucose-lowering medications
- Plasma glucose \>200 mg/dL and classic symptoms of hyperglycemia (thirst, polyuria, weight loss, blurry vision) or HbA1c \>6.5% (based on screening visit blood draw)
- Unable or unwilling to provide informed consent
Key Trial Info
Start Date :
April 4 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 5 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05343494
Start Date
April 4 2022
End Date
October 5 2022
Last Update
November 30 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tulane Office of Health Research
New Orleans, Louisiana, United States, 70112